AFT Pharmaceuticals has further extended the commercialisation agreements for its Maxigesic patented combination painkiller, signing a deal with Russian firm Nearmedic Pharma LLC as its partner for the Russian Federation.
AFT md Dr Hartley Atkinson said the market defined for paracetamol tablet and ibuprofen tablet sales in the region is estimated at US$215m, making it the 14th largest global market for the category.
The company has also secured new distribution partners for Maxigesic in Taiwan and Hong Kong complementing existing Asian networks for the company in Singapore and Malaysia.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Oct 18
